MD Labs

07/08/2025

A Deep Dive into Urine Drug Testing

Matthew Rutledge joins Podcast host Dr. Casey Grover, MD to discuss testing methodologies, detection capabilities, and emerging trends in substance use.

Listen to the Addiction Medicine Made Easy Podcast, where host Dr. Casey Grover discusses urine drug testing with Matthew Rutledge, Co-founder of MD Labs with Denis Grizelj.

03/04/2025

Best legal team in the clinical laboratory sphere. They understand the challenges laboratories face and advocate for patient care and laboratorians.

Robinson+Cole

01/29/2025

MD Labs and Owners Triumph in Lawsuit Dismissal
MD Labs and its owners, Matthew Rutledge and Denis Grizelj, today announced the successful dismissal of a qui tam lawsuit filed by serial qui tam relator, OMNI Health Care of Melbourne, FL. The United States District Court for the District of Massachusetts granted summary judgment in favor of MD Labs, Mr. Rutledge and Mr. Grizelj, dismissing all claims with prejudice.
https://www.mdlabs.com/blog/dismissal

Matthew Rutledge and Denis Grizelj, today announced the successful dismissal of a lawsuit filed by serial qui tam relator, OMNI Health Care of Melbourne, FL, solely owned by Dr. Craig Deligdish. The United States District Court for the District of Massachusetts granted summary judgment in favor of

12/24/2024

Wishing everyone happy, healthy holidays and a fantastic new year!

10/28/2024

Supreme Court Ruling May Offer Increased Protections for Pain Management Providers!

The recent Supreme Court decision overturning the Chevron doctrine may be a game changer for pain management prescribers. Federal agencies, like the DEA, may now have less power to broadly interpret laws like the Controlled Substances Act, giving providers more clarity and protection in their medical decisions. Explore how this ruling may impact your practice and patient care.

https://www.mdlabs.com/blog/chevron-overturned

10/25/2024

We’re live at the Texas Pain Society Conference!

Our specialists in Patient Monitoring and Pharmacogenetics are hosting a booth today and tomorrow at the Texas Pain Society Conference. Come by to chat with our team about how our personalized testing services can support your pain management practice.

10/24/2024

More than 75% of people have genetic variations that affect how they respond to medications, including opioids. Discover how PGx testing is revolutionizing pain management and helping doctors provide safer, more effective treatments. Check out our new blog post: https://www.rxight.com/news/pain-management

10/21/2024

With ketamine therapy clinics on the rise and at-home treatments becoming more common, it's important to stay informed about the potential risks. MD Labs offers advanced testing to detect norketamine, the key metabolite of ketamine, helping healthcare providers ensure safer treatments for their patients. Learn more about how we support accurate and reliable testing. https://www.mdlabs.com/blog/ketamine

09/20/2024

September is Pain Awareness Month!
At MD Labs, we are dedicated to empowering healthcare providers with precision testing solutions to treat chronic pain more effectively. From toxicology testing to the cutting-edge Rxight pharmacogenetics platform, we’re helping doctors make informed decisions that enhance patient outcomes. Learn how we support providers in managing chronic pain and improving patient care. https://www.mdlabs.com/blog/pain-awareness-month

08/26/2024

Stay Informed: New Medicare HCPCS Codes for Pain Management
Medicare has introduced HCPCS codes G3002 and G3003, impacting how chronic pain management is billed and documented. It's essential for healthcare providers to understand these changes to ensure compliance and optimal patient care.
Explore our latest blog to learn more: www.mdlabs.com/blog/medicare-g-codes

08/22/2024

Understanding opioid dependence requires a holistic approach that considers both genetic and environmental factors. Our latest blog dives into recent research and how healthcare providers can use these insights to improve patient outcomes. Read more on how MD Labs is helping providers navigate these challenges with advanced testing and patient-specific care. https://www.mdlabs.com/blog/opioid-dependence

07/29/2024

Understanding your genetic makeup can be the key to safer and more effective cancer medication therapy. Learn about the critical role of DPYD pharmacogenetic testing in our latest blog post. Visit our website to read more and find out how MD Labs can help with potentially life-saving lab results for you and your loved ones. https://rxight.com/news/dpyd-gene